Knowledge Distillery

ZyCoV-D is a DNA vaccine candidate, which comprises a plasmid DNA carrying spike-S gene of SARS-CoV-2 virus along with gene coding for signal peptide.…

CoronaVac, an inactivated whole-virion SARS-CoV-2 vaccine, has been shown to be well tolerated with a good safety profile in individuals aged 18 years…

The SARS-CoV-2 B.1.617 lineage was identified in October 2020 in India. It has since then become dominant in some indian regions and UK and further…

This review focuses on new evidence supporting the global immunization strategy for MS patients receiving disease-modifying drugs (DMDs), including…

The deployment of a vaccine that limits transmission and disease likely will be required to end the COVID-19 pandemic.

Control of the global COVID-19 pandemic will require the development and deployment of safe and effective vaccines.

The efficacy of two injections of the SARS-CoV-2 spike mRNA vaccines (BNT162b2 [Pfizer] and mRNA-1273 [Moderna]) in preventing symptomatic SARS-CoV-2…

As mass vaccination campaigns against COVID-19 commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes across diverse…

Assessment of the safety and efficacy of vaccines against the SARS-CoV-2 in different populations is essential, as is investigation of the efficacy…